A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis

INTRODUCTION: The main objective of this study was to examine discontinuation rates associated with delayed-release dimethyl fumarate (DMF) when used for the treatment of relapsing multiple sclerosis (MS) in a real-world, clinical practice setting. METHODS: Data were collected retrospectively from c...

Descripción completa

Detalles Bibliográficos
Autores principales: Allan, Michelle, Grant, Lindsay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229102/
https://www.ncbi.nlm.nih.gov/pubmed/31834566
http://dx.doi.org/10.1007/s40120-019-00174-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229102/
https://www.ncbi.nlm.nih.gov/pubmed/31834566
http://dx.doi.org/10.1007/s40120-019-00174-3

Ejemplares similares